{"title":"Evaluation of the Efficacy and Safety of Alternating Chelation Therapy in Transfusion-Dependent Thalassemia.","authors":"Nihan Avcu Oral, Tekin Aksu, Selin Ardali Duzgun, Tuncay Hazırolan, Erdem Karabulut, Sule Unal","doi":"10.1080/03630269.2026.2754383","DOIUrl":"https://doi.org/10.1080/03630269.2026.2754383","url":null,"abstract":"<p><p>To evaluate the efficacy and safety of weekly alternating deferasirox-deferiprone (DFX-DFP) therapy in patients with transfusion-dependent thalassemia and iron overload. This single-center retrospective study included 14 patients; because one patient had two treatment periods, 15 periods were analyzed. Patients received DFX for 3 consecutive days and DFP for 4 consecutive days in weekly cycles. Response was assessed by serum ferritin and cardiac and hepatic T2* MRI. Safety was evaluated using laboratory parameters and clinical adverse events. Pre- and post-treatment values were compared using the Wilcoxon signed-rank test. Median age at treatment initiation was 34 years (IQR: 20-37), and median treatment duration was 16 months (IQR: 12-22). Median baseline ferritin was 1571 μg/L (IQR: 1160-3001) and decreased significantly by month 3 (p = 0.006). Baseline cardiac T2* was <20 ms in 86.6% of periods. Median cardiac T2* increased from 10 ms (IQR: 8.5-15) to 21 ms (IQR: 9.9-30; p = 0.005). Hepatic T2* increased nonsignificantly (p = 0.151). Adverse events were manageable and included transient neutropenia, grade 2 hypertransaminasemia, increased creatinine, and nausea. Weekly alternating DFX-DFP therapy was associated with early ferritin reduction at month 3 and significant cardiac T2* improvement, with manageable adverse events.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"1-7"},"PeriodicalIF":1.0,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149378732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2026-11-04DOI: 10.1080/03630269.2026.2748610
Foued Maaoui, Ines Safra, Samia Mnif, Imen Moumni
{"title":"Negotiating Genetic Risk: Tunisian Adolescents' Attitudes Toward Marriage, Reproduction, and Hereditary Blood Disorders.","authors":"Foued Maaoui, Ines Safra, Samia Mnif, Imen Moumni","doi":"10.1080/03630269.2026.2748610","DOIUrl":"https://doi.org/10.1080/03630269.2026.2748610","url":null,"abstract":"<p><p>Hemoglobinopathies, such as sickle cell disease and β-thalassemia, pose a significant public health challenge in Tunisia. Effective prevention relies on informed reproductive choices shaped by genetic knowledge, socio-cultural norms, emotional bonds, and religious beliefs. This study explores how Tunisian high school students perceive genetic risk in relation to marriage and reproduction following a contextualized educational session on sickle cell disease. A qualitative cross-sectional survey was conducted among 158 final-year science students (aged 17-22, 78% female) in two public schools. Participants responded to three hypothetical scenarios involving sickle cell disease and one open-ended question on abortion. Quantitative data were analyzed descriptively, and qualitative responses were thematically coded in NVivo. Students demonstrated basic genetic understanding, though misconceptions about carrier status persisted. Emotional attachment frequently outweighed genetic considerations: 58% (92/158) were open to marrying a partner with homozygous sickle cell disease, and 83% (131/158) to marrying a heterozygous carrier. Attitudes toward abortion were strongly influenced by religious values, with 54% (85/158) disagreeing with a couple's decision not to terminate an affected pregnancy. Consanguinity did not arise spontaneously in responses. These post-exposure, scenario-conditioned findings, collected immediately after an educational session featuring patient narratives, are hypothesis-generating. They highlight the need for genetics education that integrates ethical, emotional, and culturally relevant discussions and underscore the importance of further research on unprompted attitudes.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"1-13"},"PeriodicalIF":1.0,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149320761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2026-11-04DOI: 10.1080/03630269.2026.2753446
Tuan Minh Tran, Hung Minh Do, Trung Hieu Nguyen, Phuong Tan Dinh, Nguyen The Nguyen Phung, Mai Anh Thi Nguyen
{"title":"Congenital Methemoglobinemia in a Vietnamese Adolescent: A Dyshemoglobinemia with Diagnostic Challenges, Literature Review, and Diagnostic Algorithm.","authors":"Tuan Minh Tran, Hung Minh Do, Trung Hieu Nguyen, Phuong Tan Dinh, Nguyen The Nguyen Phung, Mai Anh Thi Nguyen","doi":"10.1080/03630269.2026.2753446","DOIUrl":"10.1080/03630269.2026.2753446","url":null,"abstract":"<p><p>Methemoglobinemia is a disorder of hemoglobin redox homeostasis in which the iron in heme is oxidized to the ferric (Fe3+) state, impairing oxygen transport. Congenital methemoglobinemia due to cytochrome b5 reductase (CYB5R) deficiency is a rare autosomal recessive disorder causing persistent central cyanosis. We report the first documented case in Vietnam - a 15-year-old boy with a 10-year history of unexplained central cyanosis (SpO2 85%, PaO2 140.8 mmHg). Methemoglobin (MetHb) level was 33.7%. Whole exome sequencing (WES) identified a heterozygous pathogenic <i>CYB5R3</i> variant (NM_000398.7: c.218T>C, p.Leu73Pro; ACMG: Likely Pathogenic), confirmed by Sanger sequencing, with markedly reduced CYB5R enzyme activity (NADH-ferricyanide method). No second pathogenic allele was identified in <i>CYB5R3, CYB5A, HBA1/HBA2</i>, or <i>HBB</i>, reflecting the known limitations of short-read WES in detecting structural variants and deep intronic mutations; thus, molecular confirmation remains incomplete despite definitive clinical and enzymatic evidence. Diagnosis was delayed 10 years from symptom onset and 8 hours after admission, attributable to the unavailability of pulse co-oximetry. Acute intravenous methylene blue (MB) produced rapid clinical improvement. Long-term ascorbic acid monotherapy proved insufficient (MetHb 10.4% at 3 months), whereas escalation to oral MB achieved sustained remission (MetHb 2.8% at 12 months). A comprehensive review of 71 published pediatric cases reveals marked geographic disparity (64.8% from India; Southeast Asia is critically underrepresented) and an average diagnostic delay of 6 years. We propose a practical diagnostic algorithm for congenital methemoglobinemia in resource-limited settings. This case underscores the need for heightened clinical awareness of <i>CYB5R3</i>-related hemoglobin disorders in underdiagnosed populations.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"1-10"},"PeriodicalIF":1.0,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2026-11-04DOI: 10.1080/03630269.2026.2756997
Chathuni U Wimalasiri, Uditha B Dassanayake, Madunil A Niriella, Anuja P Premawardhena
{"title":"Probable Deferasirox-Associated Acute-on-Chronic Liver Failure in Non-Transfusion-Dependent β-Thalassemia with Iron-Related Cirrhosis: A Case Report.","authors":"Chathuni U Wimalasiri, Uditha B Dassanayake, Madunil A Niriella, Anuja P Premawardhena","doi":"10.1080/03630269.2026.2756997","DOIUrl":"https://doi.org/10.1080/03630269.2026.2756997","url":null,"abstract":"<p><p>Oral iron chelation with deferasirox is widely used to manage iron overload in patients with thalassemia syndromes. Clinically significant drug-induced liver injury (DILI) attributed to deferasirox is uncommon but has been reported. We describe a 49-year-old man with non-transfusion-dependent β-thalassemia intermedia (β-thalassemia trait with α-globin gene triplication), substantial iron overload, cirrhosis, and previously treated hepatocellular carcinoma who developed acute hepatic decompensation during deferasirox therapy. He presented with progressive jaundice, ascites, and encephalopathy. Laboratory evaluation showed profound conjugated hyperbilirubinemia with relatively modest aminotransferase elevations, consistent with a predominantly cholestatic pattern of injury. Causality assessment using the Roussel Uclaf Causality Assessment Method (RUCAM) yielded a score of 7, indicating a probable association with deferasirox. Despite drug withdrawal and supportive care, including plasma exchange, liver failure persisted, and the patient was evaluated for urgent transplantation. This case underscores the vulnerability of patients with limited hepatic reserve to chelator-associated hepatotoxicity and highlights the need for individualized chelation strategies and close biochemical monitoring.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"1-4"},"PeriodicalIF":1.0,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149333739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2026-10-30DOI: 10.1080/03630269.2026.2754394
Bipasha Banerjee, Tuphan Kanti Dolai, Kaustav Ghosh, Aditi Sen, Abhishek Sharma
{"title":"Genotype-Phenotype Spectrum, Socio-Demographic Drivers, and the Protective Impact of Fetal Hemoglobin in Sickle Cell Disease: A Cross-Sectional Analysis from West Bengal, India.","authors":"Bipasha Banerjee, Tuphan Kanti Dolai, Kaustav Ghosh, Aditi Sen, Abhishek Sharma","doi":"10.1080/03630269.2026.2754394","DOIUrl":"https://doi.org/10.1080/03630269.2026.2754394","url":null,"abstract":"<p><p>Sickle cell disease (SCD) in India is often linked to the Arab-Indian haplotype, characterized by elevated fetal hemoglobin (HbF) levels and a relatively mild phenotype. However, data on genetic heterogeneity and genotype-phenotype correlations in Eastern India remain limited. This hospital-based cross-sectional study at Nilratan Sircar Medical College and Hospital, Kolkata, West Bengal, included 204 participants: 94 with SCD, 80 with sickle cell trait, and 30 healthy controls. Clinical, hematological, and socio-demographic data were analyzed. Among SCD patients (57 males, 37 females; mean age 24.2 years), 85.1% had a monthly household income ≤ ₹10,000, and 55.3% reported consanguinity. Geospatial mapping revealed clustering in North 24 Parganas, South 24 Parganas, and Kolkata. The predominant genotype was HbS-β thalassemia (62.8%). The median values for hemoglobin, HbF, platelet count, and leukocyte count were 8.7 g/dL, 17.4%, 214 × 10<sup>9</sup>/L, and 8.8 × 10<sup>9</sup>/L, respectively. HbF expression showed marked inter-individual variability, ranging from 7.7% to 49.6%. HbF levels showed a significant inverse correlation with leukocyte count (ρ=-0.733, p < 0.001), annual transfusion frequency (r=-0.387, 95% CI [-0.546, -0.200], p < 0.001), and vaso-occlusive crisis (VOC) frequency (r=-0.364, 95% CI [-0.528, -0.175], p < 0.001). In conclusion, SCD in West Bengal shows marked genetic and clinical heterogeneity, with HbS-β thalassemia as the predominant genotype. Higher HbF levels were associated with lower leukocyte counts, fewer transfusions, and fewer VOCs, supporting its role as a disease modifier. However, persistent variability suggests additional genetic and environmental influences, highlighting the need for region-specific screening and individualized management.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"1-13"},"PeriodicalIF":1.0,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149297093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2026-10-25DOI: 10.1080/03630269.2026.2750938
Ernest Boachie, Nii Boi-Doku Pepra-Ameyaw, Nyanyuie Kodjo Lovi, Amma Anima Benneh-Akwasi Kuma
{"title":"Homozygous Deletional Hereditary Persistence of Fetal Hemoglobin in Ghanaian Twins: A Case Report.","authors":"Ernest Boachie, Nii Boi-Doku Pepra-Ameyaw, Nyanyuie Kodjo Lovi, Amma Anima Benneh-Akwasi Kuma","doi":"10.1080/03630269.2026.2750938","DOIUrl":"https://doi.org/10.1080/03630269.2026.2750938","url":null,"abstract":"<p><p>Hereditary persistence of fetal hemoglobin (HPFH) is a benign genetic condition characterized by continued expression of fetal hemoglobin (HbF) into adulthood. We report the case of a 26-year-old Ghanaian woman who was incidentally diagnosed with homozygous deletional HPFH during evaluation for flank pain. Laboratory testing revealed 100% HbF, erythrocytosis, and normal red cell indices. Family screening showed an identical phenotype in her monozygotic twin, an HbF level of 29% in her mother, and a normal hemoglobin electrophoresis pattern in one sibling. Homozygous deletional HPFH is rare, and this case contributes to the limited literature on adult presentations.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"1-3"},"PeriodicalIF":1.0,"publicationDate":"2026-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149266567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2026-10-25DOI: 10.1080/03630269.2026.2749724
Jatin Sarmah, Trinayani Bordoloi, Yogita Sharma, Madhusmita Bal, Deepa Bhat, Shaily B Surti, Parikipandla Sridevi, Manoranjan Ranjit, Rabindra K Jena, Bontha V Babu
{"title":"Seasonal, Geographical and Sociodemographic Variation in Coping Strategies Among Individuals with Sickle Cell Disease: A Multisite Study in India.","authors":"Jatin Sarmah, Trinayani Bordoloi, Yogita Sharma, Madhusmita Bal, Deepa Bhat, Shaily B Surti, Parikipandla Sridevi, Manoranjan Ranjit, Rabindra K Jena, Bontha V Babu","doi":"10.1080/03630269.2026.2749724","DOIUrl":"https://doi.org/10.1080/03630269.2026.2749724","url":null,"abstract":"<p><p>The clinical manifestations of sickle cell disease (SCD) vary considerably, and include vaso-occlusive and pain events. By utilizing various coping strategies, people with SCD aim to reduce pain intensity and improve quality of life. The present study, with a longitudinal, repeated-measures design, was conducted among adults with SCD across five districts of India to examine the coping behaviors. A cohort of 124 adult patients from a previous registry was included. Coping strategies, under three domains: (i) Problem-Focused Coping (PFC), (ii) Emotion-Focused Coping (EFC), and (iii) Avoidant-Focused Coping (AFC), were assessed using the Brief COPE questionnaire across four seasons. Sociodemographics were also collected. Separate linear mixed-effects models were fitted for PFC, EFC and AFC to account for repeated measurements across four seasons, with season, study site, age group, gender, annual income, education and occupation included as fixed effects. Linear mixed-effects analyses showed that study site and season were significantly associated with all three coping domains (all p ≤ 0.001). Gender was significantly associated with PFC (p = 0.015) and EFC (p = 0.048). Age group, annual income, education and occupation were not significantly associated. Adjusted mean scores were highest during winter for PFC, EFC and AFC. These findings highlight the importance of contextual and gender-related differences in understanding coping mechanisms. Integrating context-sensitive psychosocial support and coping assessment into comprehensive SCD care may help address patients' differing support needs across settings and seasons. Further research should examine associations between specific coping strategies and clinical outcomes including pain, vaso-occlusive events and quality of life. Coping strategies may be integrated to strengthen patient-centred care.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"1-9"},"PeriodicalIF":1.0,"publicationDate":"2026-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149266504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HemoglobinPub Date : 2026-10-15DOI: 10.1080/03630269.2026.2725724
Dina Tluli, Omar Tluli, Abdelrahman A Karen, Mahd M Abujbara, Omar Sorour, Alaa Abdelhamid, Dahab Ghith, Mohamed A Yassin
{"title":"Precision Medicine in Sickle Cell Disease: From Molecular Pathways to Curative Strategies.","authors":"Dina Tluli, Omar Tluli, Abdelrahman A Karen, Mahd M Abujbara, Omar Sorour, Alaa Abdelhamid, Dahab Ghith, Mohamed A Yassin","doi":"10.1080/03630269.2026.2725724","DOIUrl":"https://doi.org/10.1080/03630269.2026.2725724","url":null,"abstract":"<p><p>Sickle cell disease (SCD) is a monogenic β-globin disorder characterized by hemoglobin S polymerization, hemolysis, and vaso-occlusion, yet it exhibits remarkable clinical heterogeneity. Despite advances in supportive care and disease-modifying therapies, substantial variability in severity, treatment response, and long-term outcomes persists. Therefore, this review aims to examine the biological and clinical foundations of precision medicine in SCD, emphasizing genomic modifiers, molecular pathways, and phenotype-driven therapeutic strategies. Key pathogenic pathways including hemoglobin polymerization, vascular adhesion, and inflammatory and oxidative amplification have enabled the development of targeted agents such as hydroxyurea, voxelotor, crizanlizumab, and L-glutamine, each demonstrating domain-specific targets. Pharmacogenomic insights, particularly involving fetal hemoglobin regulatory loci (e.g. <i>BCL11A</i> and <i>HBS1L-MYB</i>), further elucidate variability in disease expression and therapeutic response. Emerging curative approaches, including allogeneic hematopoietic stem cell transplantation, lentiviral gene addition, and CRISPR-Cas9-mediated genome editing, represent transformative applications of precision hematology. Collectively, these advances support a paradigm shift from generalized symptom management toward biologically informed, individualized care. Continued integration of genomic profiling, biomarker stratification, and equitable implementation frameworks will be essential to translate precision strategies into sustainable improvements in global SCD outcomes.</p>","PeriodicalId":12997,"journal":{"name":"Hemoglobin","volume":" ","pages":"1-17"},"PeriodicalIF":1.0,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149181511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}